BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 8019452)

  • 21. Frequency and indication of unrelated bone marrow transplants in Europe. European Group of Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1993; 11 Suppl 1():62-5. PubMed ID: 8448551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic stem cell transplantation in Europe 1998.
    Gratwohl A; Passweg J; Baldomero H; Hermans J; Urbano-Ispizua A;
    Hematol J; 2000; 1(5):333-50. PubMed ID: 11920211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone marrow transplantation].
    Speck B; Gratwohl A; Tichelli A; Nissen C
    Schweiz Med Wochenschr; 1995 Aug; 125(33):1515-32. PubMed ID: 7676241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
    Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
    Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
    Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EBMT activity survey 2009: trends over the past 5 years.
    Baldomero H; Gratwohl M; Gratwohl A; Tichelli A; Niederwieser D; Madrigal A; Frauendorfer K;
    Bone Marrow Transplant; 2011 Apr; 46(4):485-501. PubMed ID: 21358689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
    Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
    Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.
    Gratwohl A; Schmid O; Baldomero H; Horisberger B; Urbano-Ispizua A;
    Bone Marrow Transplant; 2004 Nov; 34(10):855-75. PubMed ID: 15517006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey on haematopoietic stem cell transplantation for children in Europe.
    Miano M; Cancedda R; Hartmann O; Cornish J; Locatelli F; Egeler RM; Slavin S; Veys P; Ortega J; Peters C; Wynn RF; Iori AP; Fagioli F; Ljungmann P; Niethammer D; Bordigoni P; Dini G;
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S3-8. PubMed ID: 15812526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of allogeneic bone marrow transplantation in leukemia: a report from the International Bone Marrow Transplant Registry.
    Bortin MM; Gale RP
    Clin Transpl; 1987; ():127-40. PubMed ID: 3154378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Basic and clinical studies on patients who have undergone autologous or allogeneic bone marrow transplantation].
    Kasai M; Imai K; Seto K; Kobayashi N; Kawamura K; Higa T; Ariyama T; Meguro J; Kukita K; Yonekawa M
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):589-96. PubMed ID: 3065193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous versus allogeneic BMT in AML: the European experience. Report of the EBMT--Pediatric Diseases Working Party.
    Klingebiel T; Pession A; Paolucci P; Rondelli R
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():49-52. PubMed ID: 8932799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.